Browse by Person

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Number of items: 4.

Article

De Angelis, F, Connick, P, Parker, RA et al. (25 more authors) (2020) Amiloride, fluoxetine or riluzole to reduce brain volume loss in secondary progressive multiple sclerosis: the MS-SMART four-arm RCT. Efficacy and Mechanism Evaluation, 7 (3). ISSN 2050-4365

Chataway, J, De Angelis, F, Connick, P et al. (65 more authors) (2020) Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial. The Lancet Neurology, 19 (3). pp. 214-225. ISSN 1474-4422

Connick, P, De Angelis, F, Parker, RA et al. (21 more authors) (2018) Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis. BMJ Open, 8 (8). 021944. ISSN 2044-6055

Proceedings Paper

Doshi, A, De Angelis, F, Muhlert, N et al. (21 more authors) (2018) Multiple Sclerosis Impact Scale and brain volume are independent predictors of cognitive impairment in Secondary Progressive Multiple Sclerosis. In: European Journal of Neurology. 4th Congress of the European Academy of Neurology, 16-19 Jul 2018, Lisbon, Portugal. Wiley , pp. 69-70.

This list was generated on Sat Aug 1 17:07:41 2020 BST.